NDC 0591-2832

bexarotene

Bexarotene

bexarotene is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Bexarotene.

Product ID0591-2832_b1f0a062-8046-4675-959c-d70c003e0839
NDC0591-2832
Product TypeHuman Prescription Drug
Proprietary Namebexarotene
Generic NameBexarotene
Dosage FormCapsule, Liquid Filled
Route of AdministrationORAL
Marketing Start Date2021-11-11
Marketing CategoryANDA /
Application NumberANDA209931
Labeler NameActavis Pharma, Inc.
Substance NameBEXAROTENE
Active Ingredient Strength75 mg/1
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0591-2832-01

100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01)
Marketing Start Date2021-11-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "bexarotene" or generic name "Bexarotene"

NDCBrand NameGeneric Name
0054-0399Bexarotenebexarotene
0378-6955BexaroteneBexarotene
0591-2832bexarotenebexarotene
0832-0285BexaroteneBexarotene
42292-007BexaroteneBexarotene
43975-315BexaroteneBexarotene
68682-003bexarotenebexarotene
69238-1250BexaroteneBexarotene
0187-5525Targretinbexarotene
0187-5526Targretinbexarotene

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.